Clinical Trial Update: VenusP-Valve™ System Long-term Follow-up 6-10 Years

View source ↗

Summary

This is a clinical trial update on the VenusP-Valve System focusing on 6- to 10-year follow-up in native right ventricular outflow tract dysfunction. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Right Ventricular Outflow Tract Dysfunction

Drugs mentioned

• VenusP-Valve System

Snippet

Sponsor: Venus MedTech (HangZhou) Inc. | Conditions: Native Right Ventricle Outflow Tract(RVOT) Dysfunction | Status: NOT_YET_RECRUITING